Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ascorbic acid/bicarbonate/glutathione inhalation - Renovion

Next Previous
Drug Profile

Ascorbic acid/bicarbonate/glutathione inhalation - Renovion

Alternative Names: ARINA-1; Bicarbonate/glutathione/ascorbic acid inhalation - Renovion; Glutathione/bicarbonate/ascorbic acid inhalation - Renovion; Inhaled L-glutathione - Renovion

Latest Information Update: 28 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of North Carolina at Chapel Hill
  • Developer Renovion
  • Class Anti-inflammatories; Antiasthmatics; Antibronchitics; Antifibrotics; Antineoplastics; Chemoprotectants; Electrolytes; Furans; Oligopeptides; Small molecules; Sugar acids; Vitamins
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cystic fibrosis; Lung disorders
  • New Molecular Entity No

Highest Development Phases

  • Phase III Bronchiolitis obliterans
  • Phase II Bronchiectasis
  • No development reported Chronic obstructive pulmonary disease; Cystic fibrosis

Most Recent Events

  • 28 Nov 2024 No recent reports of development identified for clinical-Phase-Unknown development in Chronic-obstructive-pulmonary-disease in USA (Inhalation)
  • 30 Apr 2024 Topline efficacy and adverse events data from the phase II CLIMB trial in Bronchiectasis were released by Renovion
  • 01 Mar 2024 Renovion completes a phase II trial in Bronchiectasis in USA (Inhalation) (NCT05495243)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top